XML 104 R86.htm IDEA: XBRL DOCUMENT v3.24.0.1
STOCK-BASED COMPENSATION PLANS (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation $ 59 $ 35 $ 44
Tax benefit related to stock-based compensation 14 9 11
Unrecognized stock-based compensation for non-vested options and awards $ 27    
Unrecognized stock-based compensation awards weighted-average period 1 year 7 months 6 days    
Shares authorized under stock-based compensation plans (in shares) 20,000,000    
Shares remaining available for future grants (shares) 9,000,000    
Stock options [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation $ 2 $ 3 $ 5
Unrecognized stock-based compensation for non-vested options and awards $ 1    
Unrecognized stock-based compensation awards weighted-average period 0 days    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Expected volatility 46.00% 44.00% 43.00%
Expected term 6 years 6 years 6 years
Risk-free interest rate 3.64% 1.91% 0.68%
Expected dividend yield 0.00% 0.00% 0.00%
Weighted-average grant date fair value per share (in dollars per share) $ 16.77 $ 23.36 $ 23.66
Estimated fair value of options granted (millions) $ 1 $ 4 $ 4
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Outstanding, beginning balance (in shares) 1,230,757    
Granted (in Shares) 50,120    
Exercised (in shares) (24,996)    
Canceled (in shares) (86,475)    
Forfeited or expired (in shares) (7,976)    
Outstanding, ending balance (in shares) 1,161,430 1,230,757  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]      
Outstanding, beginning balance, Weighted-Average Exercise Price Per Share (in dollars per share) $ 61.45    
Granted, Weighted-Average Exercise Price Per Share (in dollars per share) 58.54    
Exercised, Weighted-Average Exercise Price Per Share (in dollars per share) 35.44    
Canceled, Weighted-Average Exercise Price Per Share (in dollars per share) 68.95    
Fofeited or expired, Weighted-Average Exercise Price Per Share (in dollars per share) 56.37    
Outstanding, ending balance, Weighted-Average Exercise Price Per Share (in dollars per share) $ 61.36 $ 61.45  
Outstanding, Weighted-Average Contractual Life 5 years 1 month 6 days 5 years 7 months 6 days  
Outstanding, Aggregate Intrinsic Value $ 0 $ 1  
Exercisable, Outstanding (in shares) 883,061    
Exercisable, Weighted-Average Exercise Price Per Share (in dollars per share) $ 62.84    
Exercisable, Weighted-Average Contractual Life 4 years 6 months    
Exercisable, Aggregate Intrinsic Value $ 0    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract]      
Vested or expected to vest, Shares 1,161,430    
Vested or expected to vest, Weighted-Average Exercise Price Per Share (in dollars per share) $ 61.36    
Vested or expected to vest, Weighted-Average Contractual Life 5 years 1 month 6 days    
Vested or expected to vest, Aggregate Intrinsic Value $ 0    
Intrinsic value of option exercises 0 0 3
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 4 4 4
Stock awards [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation 39 $ 14 20
Unrecognized stock-based compensation for non-vested options and awards $ 26    
Unrecognized stock-based compensation awards weighted-average period 1 year 7 months 6 days    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Non-vested, beginning balance (in shares) 106,760    
Granted (in shares) 1,245,008    
Vested (in shares) (389,231)    
Forfeited (in shares) (93,753)    
Non-vested, ending balance (in shares) 868,784 106,760  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]      
Non-vested, beginning balance, Weighted-Average Grant Date Fair Value (in dollars per share) $ 53.97    
Granted, Weighted-Average Grant Date Fair Value (in dollars per share) 51.99    
Vested, Weighted-Average Grant Date Fair Value (in dollars per share) 51.03    
Forfeited, Weighted-Average Grant Date Fair Value (in dollars per share) 61.97    
Non-vested, ending balance, Weighted-Average Price Per Share (in dollars per share) $ 51.95 $ 53.97  
Non-vested, Weighted-Average Contractual Life 1 year 8 months 12 days 2 years 10 months 24 days  
Non-vested, Total Instrinsic Value (in dollars) $ 34 $ 11  
Deferred stock awards [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation 1 1 1
Employee stock purchase plan [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Stock-based compensation $ 17 $ 17 $ 18
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]      
Granted (in shares) 1,855,608 1,292,489 1,254,393
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]      
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent 85.00%    
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate 10.00%